CD4 T-cell, CD4/CD8 Ratio Improvement and a General Reduction in Inflammatory Biomarkers with Low-Level Viremia (LLV) up to Week 192 with Fostemsavir (FTR)-Based Regimens in Individuals with Multidrug-Resistant (MDR) HIV-1

Category Primary study
JournalOpen Forum Infect. Dis.
Year 2025
This article has no abstract
Epistemonikos ID: 1cb3fe1bd3596be6192b8f1472d26f81d41ff217
First added on: Jun 14, 2025